Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
22.90
-1.16 (-4.82%)
At close: Nov 6, 2026

SHA:688806 Statistics

Total Valuation

SHA:688806 has a market cap or net worth of CNY 10.55 billion. The enterprise value is 10.12 billion.

Market Cap10.55B
Enterprise Value 10.12B

Important Dates

The last earnings date was Thursday, October 29, 2026.

Earnings Date Oct 29, 2026
Ex-Dividend Date n/a

Share Statistics

SHA:688806 has 460.55 million shares outstanding. The number of shares has increased by 11.40% in one year.

Current Share Class 460.55M
Shares Outstanding 460.55M
Shares Change (YoY) +11.40%
Shares Change (QoQ) +13.85%
Owned by Insiders (%) 21.71%
Owned by Institutions (%) 31.43%
Float 209.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 60.14
PB Ratio 12.16
P/TBV Ratio 12.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 57.68
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.73, with a Debt / Equity ratio of 1.01.

Current Ratio 4.73
Quick Ratio 4.23
Debt / Equity 1.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -24.31

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -28.66%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 200,191
Profits Per Employee -514,163
Employee Count876
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 23.76
200-Day Moving Average n/a
Relative Strength Index (RSI) 47.58
Average Volume (20 Days) 7,610,660

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:688806 had revenue of CNY 175.37 million and -450.41 million in losses. Loss per share was -1.12.

Revenue175.37M
Gross Profit 121.82M
Operating Income -437.69M
Pretax Income -454.04M
Net Income -450.41M
EBITDA -410.77M
EBIT -437.69M
Loss Per Share -1.12
Full Income Statement

Balance Sheet

The company has 1.33 billion in cash and 874.91 million in debt, with a net cash position of 454.27 million or 0.99 per share.

Cash & Cash Equivalents 1.33B
Total Debt 874.91M
Net Cash 454.27M
Net Cash Per Share 0.99
Equity (Book Value) 867.03M
Book Value Per Share 1.90
Working Capital 1.24B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -409.45 million and capital expenditures -125.56 million, giving a free cash flow of -535.01 million.

Operating Cash Flow -409.45M
Capital Expenditures -125.56M
Depreciation & Amortization 26.92M
Net Borrowing 255.94M
Free Cash Flow -535.01M
FCF Per Share -1.16
Full Cash Flow Statement

Margins

Gross margin is 69.47%, with operating and profit margins of -249.58% and -256.84%.

Gross Margin 69.47%
Operating Margin -249.58%
Pretax Margin -258.91%
Profit Margin -256.84%
EBITDA Margin -234.23%
EBIT Margin -249.58%
FCF Margin n/a

Dividends & Yields

SHA:688806 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -11.40%
Shareholder Yield -11.40%
Earnings Yield -4.87%
FCF Yield -5.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3